COMMUNIQUÉS West-GlobeNewswire

AB Science announces the initiation of coverage of its stock by Maxim Group with a target price of EUR 4.0 per share
18/12/2025
PRESS RELEASE AB SCIENCE ANNOUNCES THE INITIATION OF COVERAGE OF ITS STOCK BY MAXIM GROUP WITH A TARGET PRICE OF EUR 4.0 PER SHARE Paris, December 18, 2025, 7.15pm CET AB Science SA (Euronext - FR0010557264 - AB) [...]
Tilray Accelerates U.S. Medical Cannabis Expansion After Landmark Federal Rescheduling: Launches Tilray Medical USA to Lead Nationwide Medical Cannabis Innovation and Growth
18/12/2025
Global Cannabis Leader Poised for Major U.S. Market Entry, Signaling New Era for Healthcare NEW YORK, Dec. 18, 2025 (GLOBE NEWSWIRE) -- Tilray Medical, a division of Tilray Brands, Inc. (“Tilray” or the “Company”) ( [...]
Celularity Reaches Binding Term Sheets on Financing Transactions to Support Its Strategic Vision
18/12/2025
The contemplated financing transactions would provide up to $12 Million in capital to support Celularity’s strategic priorities around longevity and preservation of human performance. FLORHAM PARK, N.J., Dec. 18, 2025 ( [...]
Organic & Natural Health to Address Policy, Integrity and Innovation at 2026 Industry Conference
18/12/2025
FT. LAUDERDALE, Fla., Dec. 18, 2025 (GLOBE NEWSWIRE) -- The Organic & Natural Health Association (Organic & Natural Health) will convene industry leaders, policymakers and changemakers for its 11th Annual [...]
Verano Founder and Chief Executive Officer George Archos Shares Celebratory Comments on Cannabis Rescheduling Announcement
18/12/2025
Verano’s active operations span 13 states, comprised of 15 8 dispensaries operating under the Zen Leaf ™ and MÜV ™ retail banners, and 15 cultivation and processing facilities with more than 1.1 million square feet of [...]
Foundation for Sarcoidosis Research Publishes Comprehensive Voice of the Patient Report Following Externally Led PFDD Meeting with the FDA
18/12/2025
CHICAGO, Dec. 18, 2025 (GLOBE NEWSWIRE) -- The Foundation for Sarcoidosis Research (FSR) is proud to announce the release of its comprehensive Voice of the Patient report , capturing the powerful insights, lived [...]
Bavarian Nordic Establishes Long-term Incentive Program for Members of Executive Management and Selected Employees
18/12/2025
COPENHAGEN, Denmark, December 18, 2025 – Bavarian Nordic A/S (OMX: BAVA) announced today that the Board of Directors has decided to establish a long-term incentive program for Executive Management as part of the annual [...]
Lixte Biotechnology Holdings, Inc. Announces $4.3 Million Registered Direct Offering Priced at the Market Under Nasdaq Rules
18/12/2025
BOCA RATON, FLA, Dec. 18, 2025 (GLOBE NEWSWIRE) -- Lixte Biotechnology Holdings, Inc. (NASDAQ: LIXT) (the “Company”), a biotech company focused on advancing cancer treatments, today announced that it has entered into [...]
TOMI Environmental Solutions Secures a Purchase Order of Approximately $500,000 for the Integration of SteraMist iHP Technology within a Global Biopharmaceutical Leader
18/12/2025
FREDERICK, Md., Dec. 18, 2025 (GLOBE NEWSWIRE) -- TOMI Environmental Solutions, Inc. ® (“TOMI”) (NASDAQ: TOMZ), a global leader in disinfection and decontamination solutions, announced today announced it has received a [...]
ENvue Medical’s UroShield® Kit Secures Reimbursement in the UK
18/12/2025
Peak Medical, ENvue’s Exclusive Distributor in UK, Places Significant Order after Reimbursement Decision, Projecting Future Market Demand for UroShield® Kit TYLER, Texas, Dec. 18, 2025 (GLOBE NEWSWIRE) -- ENvue Medical [...]
Alpha Tau to Present at the J.P. Morgan 2026 Healthcare Conference
18/12/2025
- The overview presentation will review some of the Company’s recent achievements as well as the outlook for upcoming data milestones - JERUSALEM, Dec. 18, 2025 (GLOBE NEWSWIRE) -- Alpha Tau Medical Ltd. ("Alpha Tau", [...]
SafeSpace Global Enters Letter of Intent with BMRT for Exclusive Deployment of Molecular-Level Weapons Detection Technology in U.S. Schools and Correctional Facilities
18/12/2025
Letter of Intent Contemplates Joint Venture and Exclusive Deployment Rights Across Estimated $6 Billion Addressable Market Knoxville, TN, Dec. 18, 2025 (GLOBE NEWSWIRE) -- SafeSpace Global Corporation (OTCID:SSGC) (“ [...]
Femasys Secures U.S. FDA Clearance for Next-Generation FemVue Diagnostic Device
18/12/2025
-- Innovative single-device solution integrates proven FemVue and FemChec ® technologies to support fallopian tube evaluation and improve workflow efficiency-- ATLANTA, Dec. 18, 2025 (GLOBE NEWSWIRE) -- Femasys Inc. ( [...]
J-Star Announces Interim Financial Results for the First Six Months of 2025
18/12/2025
TAICHUNG CITY, Taiwan, Dec. 18, 2025 (GLOBE NEWSWIRE) -- J-Star Holding Co., Ltd. (Nasdaq: YMAT) (“J-Star” or the “Company”), a leading provider of innovative carbon fiber and composite solutions across a wide range of [...]
Therapy for Women Joins the Lumina Therapy Alliance, Strengthening a National Network Serving Employers and Their Workforces
18/12/2025
Broadening national access to in-person care, with specialized expertise supporting women in high-performance workplaces NEW YORK, Dec. 18, 2025 (GLOBE NEWSWIRE) -- Lumina Therapy Alliance , the nation’s leading [...]
Crucial Innovations Retains FOCUS Capital Partners to Support Strategic Growth and Investment Initiatives
18/12/2025
LONDON, Dec. 18, 2025 (GLOBE NEWSWIRE) -- Crucial Innovations Corp . (“CINV” or “the Company”), an international pioneering medical cannabis company, announced that it has formally retained FOCUS Capital Partners (“ [...]
NeuExcell Therapeutics Reports Encouraging Clinical Results with World’s First In Situ Conversion Therapy for Malignant Glioma
18/12/2025
SINGAPORE, Dec. 18, 2025 (GLOBE NEWSWIRE) -- NeuExcell Therapeutics announced encouraging clinical results of NXL-004, the world’s first in situ conversion gene therapy for malignant glioma. The data were presented at [...]
Kane Biotech Announces Closing of Private Placement Offering with an Insider of the Company
18/12/2025
Not for distribution to U.S. news wire services or dissemination in the United States WINNIPEG, Manitoba, Dec. 18, 2025 (GLOBE NEWSWIRE) -- Kane Biotech Inc. (TSX-V:KNE) (the “Company”, “Kane” or “Kane Biotech”) [...]
ProMIS Neurosciences Exceeds Target Enrollment in PRECISE-AD Phase 1b Clinical Trial of PMN310 in Alzheimer’s Disease
18/12/2025
Large, well-powered Phase 1b study, designed to generate clinically and biologically meaningful insights in early Alzheimer’s disease Clear and near-term value inflection points, with blinded 6-month interim data [...]

Pages